Other factors, including a higher frequency of women and younger patients with cancer harboring BRAF mutation compared to those without the mutation, as well as a lower likelihood to metastasize to the soft tissue, retroperitoneum and lungs was seen across histologic groups, albeit not always in a statistically significant manner. Here, BRAF is linked to cancer.